Literature DB >> 2001033

Comparison of the systemic and coronary hemodynamic actions of desflurane, isoflurane, halothane, and enflurane in the chronically instrumented dog.

P S Pagel1, J P Kampine, W T Schmeling, D C Warltier.   

Abstract

The systemic and coronary hemodynamic effects of desflurane were compared to those of isoflurane, halothane, and enflurane in chronically instrumented dogs. Since autonomic nervous system function may significantly influence the hemodynamic actions of anesthetics in vivo, a series of experiments also was performed in the presence of pharmacologic blockade of the autonomic nervous system. Eight groups comprising a total of 80 experiments were performed on 10 dogs instrumented for measurement of aortic and left ventricular pressure, the peak rate of increase of left ventricular pressure (dP/dt), subendocardial segment length, coronary blood flow velocity, and cardiac output. Systemic and coronary hemodynamics were recorded in the conscious state and after 30 min equilibration at 1.25 and 1.75 MAC desflurane, isoflurane, halothane, and enflurane. Desflurane (+79 +/- 12% change from control) produced greater increases in heart rate than did halothane (+44 +/- 12% change from control) or enflurane (+44 +/- 9% change from control) at 1.75 MAC. Desflurane preserved mean arterial pressure to a greater degree than did equianesthetic concentrations of isoflurane. This result was attributed to a smaller effect on peripheral vascular resistance as compared to isoflurane and greater preservation of myocardial contractility as evaluated by peak positive left ventricular dP/dt and the rate of increase of ventricular pressure at 50 mmHg (dP/dt50) compared to other volatile anesthetics. Increases in diastolic coronary blood flow velocity (+19 +/- 6 and +35 +/- 12% change from control at 1.75 MAC, respectively) and concomitant decreases in diastolic coronary vascular resistance (-41 +/- 12 and -58 +/- 6% change from control at 1.75 MAC, respectively) were produced by desflurane and isoflurane. In the presence of autonomic nervous system blockade, the actions of desflurane and isoflurane were nearly identical with the exception of coronary vasodilation. After autonomic nervous system blockade, isoflurane increased coronary blood flow velocity, but desflurane did not. Furthermore, both desflurane and isoflurane continued to produce less depression of myocardial contractility than did halothane and enflurane. In summary, at equianesthetic concentrations, desflurane and isoflurane produced similar hemodynamic effects; however, in the absence of drugs that inhibit autonomic reflexes, desflurane had less negative inotropic activity and produced less decrease in arterial pressure. The coronary vasodilator actions of desflurane and isoflurane within the limitations of this model were not similar. When the increase in heart rate and rate-pressure product produced by desflurane were prevented in dogs with autonomic nervous system blockade, desflurane produced no change in coronary blood flow velocity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001033     DOI: 10.1097/00000542-199103000-00024

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

1.  Anaesthetic management of baboons undergoing heterotopic porcine cardiac xenotransplantation.

Authors:  D Santerre; R H Chen; A Kadner; D Lee-Parritz; D H Adams
Journal:  Vet Res Commun       Date:  2001-05       Impact factor: 2.459

Review 2.  Volatile anesthetics and AKI: risks, mechanisms, and a potential therapeutic window.

Authors:  Kyota Fukazawa; H Thomas Lee
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

3.  Alteration of vascular capacitance and blood flow distribution during halothane anesthesia.

Authors:  Hiroyuki Arimura; Sumio Hoka; Zeijko J Bosnjak; John P Kampine
Journal:  J Anesth       Date:  1994-12       Impact factor: 2.078

4.  Influence of desflurane, isoflurane and halothane on regional tissue perfusion in dogs.

Authors:  J C Hartman; P S Pagel; L T Proctor; J P Kampine; W T Schmeling; D C Warltier
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

Review 5.  Desflurane clinical pharmacokinetics and pharmacodynamics.

Authors:  J E Caldwell
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

6.  Isoflurane causes concentration-dependent inhibition of medullary raphé 5-HT neurons in situ.

Authors:  S L Johansen; K E Iceman; C R Iceman; B E Taylor; M B Harris
Journal:  Auton Neurosci       Date:  2015-07-17       Impact factor: 3.145

Review 7.  The clinical use of desflurane.

Authors:  E I Eger
Journal:  Yale J Biol Med       Date:  1993 Sep-Oct

8.  Pulse pressure variation and stroke volume variation under different inhaled concentrations of isoflurane, sevoflurane and desflurane in pigs undergoing hemorrhage.

Authors:  Alexandre Hideaki Oshiro; Denise Aya Otsuki; Marcelo Waldir M Hamaji; Kaleizu T Rosa; Keila Kazue Ida; Denise T Fantoni; José Otavio Costa Auler
Journal:  Clinics (Sao Paulo)       Date:  2015-12       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.